About
No bio provided
This profile has not been completed yet.
Profile AI
Farzahna Mohamed is a South African clinician-researcher whose work centers on endocrinology, diabetes, and cardiovascular risk. Affiliated with academic medicine in South Africa, her scholarship reflects a strong commitment to addressing metabolic disease within resource-constrained settings, with attention to both clinical complexity and health system challenges.
Her publications highlight expertise in lipid disorders, novel lipid-lowering therapies, and strategies targeting PCSK9 and related pathways, alongside practical evaluations of point-of-care lipid testing. She also explores access barriers to emerging cardiovascular therapies, emphasizing policy reform, affordability, and equitable implementation.
Additional contributions span pancreatic beta cell replacement, complex pituitary and thyroid disorders, tumor-induced hypoglycemia, electrolyte abnormalities, and COVID-19 risk stratification. This body of work demonstrates strength in translational endocrinology, evidence-based clinical practice, and advocacy for improved metabolic care in the South African context.
Latest publications
Most recent scholarly works and contributions.